An anaphylactic reaction without skin manifestations after general anesthesia induction: a case report Authors: Maho Suyama, Mitsuhiro Yoshida, Serika Imamura, Aya Oda, Kana Oue, Mitsuru Doi, Yoshitaka Shimizu, Hiroshi Hanamoto Published: 2026 ABSTRACT AbstractAnaphylaxis is a severe, potentially life-threatening hypersensitivity reaction. Although anaphylaxis rarely occurs during dental anesthesia, preparation for a prompt and appropriate response is crucial. Severe anaphylaxis may occur in the absence of typical skin manifestations. We encountered anaphylaxis approximately 15 min after induction of general anesthesia, presenting with a gradual decrease in SpO2, acute hypotension, and tachycardia without skin manifestations. After administration of epinephrine, the patient’s hemodynamic status improved rapidly. Elevated serum tryptase and plasma histamine levels supported this diagnosis. This case highlights the diagnostic challenges of perioperative anaphylaxis during general anesthesia because cutaneous manifestations may be absent and alternative causes of hypoxemia or circulatory collapse must also be considered. Perioperative anaphylaxis remains an important differential diagnosis, even in the absence of skin symptoms. Prompt exclusion of alternative causes and early epinephrine administration are essential for successful management. Postoperative allergological evaluation, patient education, and institutional preparedness are important for reducing the risk of recurrence and improving patient safety.Keywords: Anaphylaxis; Anesthesia, General; Anesthesia, Dental; Epinephrine; Tryptases INTRODUCTION Anaphylaxis is a sudden and potentially life-threatening allergic reaction caused by the release of mediators by mast cells, basophils, and other inflammatory cells. Anaphylaxis involves various signs and symptoms that manifest within minutes to a few hours of exposure to the triggering substance [1]. World Allergy Organization guidelines state that anaphylaxis is a severe systemic hypersensitivity reaction that typically occurs quickly and can be potentially fatal. Severe anaphylaxis is characterized by compromised airway, breathing, and circulation and skin changes. Anaphylaxis can occur without typical skin manifestations/cardiovascular shock [2]. Although anaphylaxis is a rare side effect of dental treatments, including sedation and anesthesia, prompt response and prevention of complications is essential. In this case, we experienced an anaphylactic reaction without skin changes after the induction of general anesthesia. The patient showed severe hypotension and low SpO2. Here, we present a case to discuss specific anesthetic management strategies and considerations required in such situations. Informed consent for case reporting was obtained from the patient. CASE REPORT This case report was approved by the Institutional Review Board of the Ethical Committee for Epidemiology of Hiroshima University (Approval No. E2025-0283). This case report was prepared according to the CARE guidelines. A 29-year-old man (height, 157 cm; weight, 59 kg) with a mandibular fracture sustained during a bicycle accident was scheduled for open reduction and fixation of the right mandible under general anesthesia. Although the patient presented with limited mouth opening (2.2 cm) and restricted head extension due to a mandibular fracture, he had no notable medical history. Preoperatively, his blood pressure and heart rate were 126/79 mmHg and 58 bpm, respectively. Preoperative blood tests, electrocardiography, urinalysis, pulmonary function tests, and chest radiographs revealed no significant abnormalities. The patient’s intraoperative course and hemodynamic changes are summarized in Figure 1. No pre-medications were administered. Non-invasive blood pressure, electrocardiogram (lead II), SpO2, and muscle relaxation were monitored during general anesthesia. The depth of anesthesia was monitored using an entropy monitor (GE Healthcare, Chicago, IL, USA). The baseline blood pressure, heart rate, and SpO2 were 142/88 mmHg, 65 bpm, and 99%, respectively, before induction. Oxygen was delivered via a face mask (6 L/min) and Ringer’s acetate solution was infused. Initially, video laryngoscope (McGRATH™ MAC, Aircraft Medical, Edinburgh, UK) confirmed glottis under conscious sedation (midazolam, 2 mg; fentanyl, 0.1 mg) before induction because the patient presented with limited mouth opening. Anesthesia was induced using midazolam (5 mg) and remifentanil (0.3 µg/kg/min). Rocuronium (40 mg) was administered after mask ventilation was confirmed. Nasotracheal intubation (7.0 mm inner diameter [ID]) was performed using a video laryngoscope. General anesthesia was maintained with air (2 L/min), oxygen (1 L/min), and sevoflurane (1.5%). Cefmetazole sodium was administered. Hemodynamic changes and therapeutic interventions during intraoperative anaphylaxis. Blood pressure (red) decreased and heart rate (green) increased following cefmetazole administration and improved after epinephrine administration. Symbols: ×, Start of anesthesia; ⊚, Start of surgery; △, Nasal intubation; ①, Emergency call; ②, 12-lead ECG, Echocardiography, Chest radiography; ③, Drawing blood. Note: For 0.1% epinephrine, the values in brackets ([ ]) indicate single-dose administration (mg), whereas values without brackets ([ ]) indicate continuous infusion (µg/kg/min). Cefmetazole sodium (1 mg) was dissolved in 100 mL of normal saline and continuous infusion was initiated. When anaphylaxis due to cefmetazole sodium was suspected, administration was discontinued. As 50 mL of normal saline remained, cefmetazole sodium (0.5 mg) was administered, and the cefmetazole sodium dose was recorded. SpO2 gradually decreased to <95% at 15 min after induction. We confirmed breath sounds and performed endotracheal suction. However, there were no differences in the breath sounds between the lungs, nor were there any abnormalities, and little tracheal secretion was observed. Although the inspired oxygen concentration had increased to 10 L/min, the patient’s SpO2 continued to decrease. The patient subsequently developed progressive hypotension (55/30 mmHg) and tachycardia (101 bpm). Remifentanil was discontinued, and hydroxyethyl starch, ephedrine (8 mg), and phenylephrine (0.2 mg) were administered; however, hemodynamic instability persisted. Because severe hypotension and hypoxemia persisted despite these treatments, anaphylaxis due to cefmetazole sodium, which had been administered after induction, was considered a differential diagnosis. Epinephrine (0.1 mg of 0.1% epinephrine) was administered with leg elevation. Approximately 30 min after induction, the SpO2 decreased to 86% and blood pressure to 41/20 mmHg, respectively. Although we did not observe any skin changes, the patient’s blood pressure improved following repeated intravenous bolus doses of epinephrine and subsequent continuous infusion (0.03–0.08 µg/kg/min). To evaluate other possible causes of circulatory collapse, 12-lead electrocardiogram, echocardiography, and chest radiography were performed; however, no abnormalities were detected. Blood samples for serum tryptase and plasma histamine measurements were collected approximately 35 min after the onset of severe hypotension. D-chlorpheniramine maleate (5 mg) was administered. After stabilizing the patient's hemodynamic and respiratory statuses, the surgical team considered whether the procedure should be postponed. However, because the patient's vital signs recovered and surgical treatment of the mandibular fracture was considered beneficial without further delay, the operation was continued after discussion among the surgical and anesthetic teams. Remifentanil was resumed because cefmetazole sodium was considered the most likely cause based on the temporal relationship between administration and symptom onset. No evidence suggested remifentanil as the trigger, and the patient remained hemodynamically stable after its reintroduction. The surgery was completed within 40 min. The duration of anesthesia was 2 h 32 min. The paraglottic area was observed postoperatively using video laryngoscopy. Although no significant edema was observed, extubation was deferred due to concerns regarding biphasic anaphylaxis and possible delayed airway edema following severe perioperative anaphylaxis. The patient was transferred to the intensive care unit (ICU) under sedation with propofol (10 mg/kg/h) and dexmedetomidine (0.4 µg/kg/h). We observed the paraglottic area using a bronchoscope 15 min after ICU admission. No edema was observed. Additionally, no skin changes were observed, and the patient’s vital signs were stable (SpO2, 100%; blood pressure, 112/73 mmHg; heart rate, 80 bpm). Therefore, extubation was performed after cessation of sedation. After extubation, respiratory distress and airway obstruction were not observed, and communication was clear. The patient was observed overnight in the ICU for a biphasic anaphylactic reaction and transferred to the ward the following day as there was no symptom recurrence. Blood samples were collected 24 h after the incident for serum tryptase and plasma histamine measurements. One week later, the patient was discharged without postoperative infections/complications. Intraoperative blood sample were elevated (serum tryptase, 27.5µg/L; plasma histamine, 149 ng/mL). In the blood sample obtained 24 h after the incident, the values had decreased (serum tryptase, 6.3 µg/L; plasma histamine, 2.00 ng/mL). The elevated serum tryptase and plasma histamine levels suggested an anaphylactic reaction caused by the drugs administered during general anesthesia induction. Therefore, a prick test was performed at our hospital’s dermatology department to identify the causative agent (fentanyl citrate, remifentanil hydrochloride, midazolam, rocuronium bromide, hydrocortisone sodium succinate, tranexamic acid, lidocaine adrenaline, and cefmetazole sodium). We conducted the same tests on drugs that may be used in future surgeries (lidocaine adrenaline bitartrate, propitocaine hydrochloride felypressin, and clindamycin). However, all results were negative. Intradermal testing was recommended for a more detailed investigation, but the patient refused. DISCUSSION The general features of anaphylaxis include symptoms in the skin, mucous membranes, respiratory, cardiovascular, central nervous, and gastrointestinal system [2]. Although many anesthesiologists believe that there are cutaneous signs of anaphylactic reactions, they can be subtle/absent in approximately 20% of reactions [3]. One study reported that mucocutaneous symptoms were often absent, especially in severe cases [4]. Therefore, anaphylactic reactions should be suspected if acute circulatory changes/decreased SpO2 are observed. We observed a gradual decrease in SpO2 levels after general anesthesia induction. First, we believed that this was due to one-lung intubation, mucus plugging, or endotracheal tube obstruction. Although we performed auscultation and tracheal suctioning, and checked the tidal volume and anesthetic circuit, there were no specific abnormalities. Subsequently, SpO2 decreased, blood pressure suddenly decreased, and the heart rate increased. This was possibly due to pulmonary embolism. We performed 12 lead-electrocardiography, echocardiography, and chest radiography to rule out pulmonary embolism/cardiac tamponade. However, no abnormalities were observed. Furthermore, the amount of EtCO2 decreased gradually. Therefore, pulmonary thromboembolism and cardiogenic shock were considered unlikely, and only epinephrine improved the condition. According to the World Allergy Organization Anaphylaxis Guidance 2020, anaphylaxis can be diagnosed when acute onset of hypotension, bronchospasm, or laryngeal involvement occurs after exposure to a known/highly probable allergen (minutes to several hours), even in the absence of typical skin involvement [2]. In the present case, severe hypotension developed after the administration of perioperative agents, without any cutaneous manifestations. Therefore, we considered that an anaphylactic reaction was the most probable diagnosis. Although the prick tests for all the tested agents were negative, cefmetazole sodium was considered the most likely trigger based on the temporal relationship between drug administration and symptom onset. Severe hypotension developed approximately 15–20 min after cefmetazole administration. Antibiotic use is among the most frequently reported causes of perioperative anaphylaxis. Rocuronium was also considered a possible causative agent, because neuromuscular blocking agents are well-known triggers of perioperative anaphylaxis. However, a large epidemiological study reported that 95% of NMBA-induced reactions occurred within 5 min of administration [5]. In the present case, severe hypotension developed approximately 25 min after rocuronium administration, whereas the onset of symptoms was temporally associated with cefmetazole administration. Therefore, cefmetazole sodium was considered the most likely trigger. Latex allergies are also considered a potential cause. However, latex exposure was considered less likely because latex-free gloves are routinely used by the anesthesia team and circulating nurses during intraoperative management. Healthcare workers involved in the patient’s preoperative management used the same gloves, and no allergic symptoms were observed before surgery. Nevertheless, the causative agent could not be definitively identified because the all prick tests were negative, and intradermal testing could not be performed owing to patient refusal. Epinephrine is widely used as a first-line drug for the treatment of anaphylactic shock; however, clear guidelines regarding its dosage are lacking. However, international consensus and national epidemiological studies recommended repeated intravenous bolus doses of epinephrine (0.05–0.1 mg) and continuous infusion for maintaining blood pressure in severe perioperative anaphylaxis [6,7]. Therefore, we administered epinephrine (0.1 mg) third and started continuous infusion (0.03–0.08µg/kg/min). This improved the patient’s hemodynamic status. This was consistent with the recommendations and appropriate. Although epinephrine remains the first-line treatment for severe perioperative anaphylaxis, adjunctive therapies such as antihistamines and corticosteroids may also be considered depending on the clinical situation. Anaphylaxis is classified as IgE-mediated immunological mechanism, IgG/immune complex complement-mediated immunological mechanism, non-immunological mechanism involving direct mast-cell activation, and idiopathic anaphylaxis with no clear trigger [2]. Traditionally, anaphylactic reactions have been explained by IgE-dependent pathways. However, recent evidence suggests that symptoms can be triggered by non-IgE-dependent pathways [8]. Although serum tryptase and plasma histamine levels were elevated in the intraoperative blood samples, their measured values decreased within 24 h, and prick tests were negative. Therefore, the anaphylactic reaction might have been caused by a non-IgE mechanism. Because the patient may require future surgical procedures under general anesthesia, careful perioperative evaluation and preparation for possible recurrent anaphylaxis was important. The patient was referred for postoperative allergological evaluation to assess suspected perioperative agents, avoid potential causative drugs, and identify possible alternative agents for future anesthesia. However, all prick tests were negative, and the patient declined intradermal testing. Although the causative agent could not be definitively identified, perioperative anaphylactic events and results of allergological testing were documented in medical records to facilitate safer anesthetic management in the future. This case highlights the importance of encouraging patients to undergo detailed postoperative investigations after perioperative anaphylaxis. In addition, patients should be advised to carry information regarding perioperative anaphylactic events and suspected causative agents as future procedures requiring general anesthesia may be performed at other institutions. If general anesthesia is required for this patient in the future, additional allergological evaluation, including intradermal testing, should be performed to facilitate the identification of the causative agent. Until a definitive trigger is identified, avoidance of cefmetazole, which is considered the most likely causative agent based on its temporal relationship with symptom onset, and the use of alternative antibiotics should be considered. In addition, detailed documentation of the perioperative anaphylactic event and thorough preoperative communication among healthcare providers are important to minimize the risk of recurrence and to ensure prompt recognition and management should a similar reaction occur. Consequently, our hospital improved the system to manage anaphylactic reactions, including a standardized response kit (containing collection tubes for plasma histamine, serum tryptase, hydrocortisone sodium succinate, d-chlorpheniramine maleate, and epinephrine and an instruction manual). The availability of standardized response kits is crucial for maintaining patient safety. Although anaphylaxis without cutaneous manifestations has been reported previously, this case highlights the diagnostic challenges encountered during general anesthesia. In anesthetized patients, sudden circulatory collapse/hypoxemia may be caused by various conditions, including pulmonary embolism, cardiogenic shock, airway obstruction, or anesthetic equipment problems. Therefore, perioperative anaphylaxis remains an important differential diagnosis, even in the absence of skin manifestations. Prompt exclusion of alternative causes and early epinephrine administration are essential for successful management. This case emphasizes the importance of comprehensive perioperative management after anaphylaxis, including appropriate postoperative investigations, patient education, and institutional preparedness. These measures may facilitate safer anesthetic care and improve patient safety in future procedures. Footnotes AUTHOR CONTRIBUTIONS: Maho Suyama: Conceptualization, Investigation, Writing– original draft.Mitsuhiro Yoshida: Conceptualization, Investigation, Supervision, Writing – review & editing.Serika Imamura: Investigation, Writing – review & editing.Aya Oda: Investigation, Writing – review & editing.Kana Oue: Investigation, Writing – review & editing.Mitsuru Doi: Investigation, Writing – review & editing.Yoshitaka Shimizu: Investigation, Writing – review & editing.Hiroshi Hanamoto: Supervision, Writing – review & editing. Maho Suyama: Conceptualization, Investigation, Writing– original draft. Maho Suyama: Conceptualization, Investigation, Writing– original draft. Mitsuhiro Yoshida: Conceptualization, Investigation, Supervision, Writing – review & editing. Mitsuhiro Yoshida: Conceptualization, Investigation, Supervision, Writing – review & editing. Serika Imamura: Investigation, Writing – review & editing. Serika Imamura: Investigation, Writing – review & editing. Aya Oda: Investigation, Writing – review & editing. Aya Oda: Investigation, Writing – review & editing. Kana Oue: Investigation, Writing – review & editing. Kana Oue: Investigation, Writing – review & editing. Mitsuru Doi: Investigation, Writing – review & editing. Mitsuru Doi: Investigation, Writing – review & editing. Yoshitaka Shimizu: Investigation, Writing – review & editing. Yoshitaka Shimizu: Investigation, Writing – review & editing. Hiroshi Hanamoto: Supervision, Writing – review & editing. Hiroshi Hanamoto: Supervision, Writing – review & editing. DECLARATIONS OF INTERESTS: The authors declare no conflict of interest. STATEMENT INFORMED CONSENT AND INSTITUTIONAL REVIEW BOARD APPROVAL: Written informed consent was obtained from the patient to report the case. This case report was approved by Ethical Committee for Epidemiology of Hiroshima University (approval number: E2025-0283). ARTIFICIAL INTELLIGENCE DECLARATION: The authors declare that no artificial intelligence (AI) or AI-assisted technologies were used in the preparation of this manuscript. References